Glycyrrhizic acid can attenuate metabolic deviations caused by a high-sucrose diet without causing water retention in male sprague-dawley rats

Nutrients

Volumn 6, Issue 11, 2014, Pages 4856-4871

  Fernando, Hamish Alexander ^a   Chandramouli, Chanchal ^a   Rosli, Dayang ^a   Lam, Yi Lyn ^a   Yong, Sheau Ting ^a   Yaw, Hui Ping ^a   Ton, So Ha ^a   Kadir, Khalid Abdul ^a   Sainsbury, Amanda ^b  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

11 HSD2; Angiotensin II; Edema; Electrolytes; Glycyrrhizic acid; High sucrose diet; Metabolic syndrome; Side effects

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ANGIOTENSIN II; GLYCYRRHIZIC ACID; LEPTIN; POTASSIUM; SODIUM; SUGAR INTAKE;

ABSENCE OF SIDE EFFECTS; ADIPOCYTE; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CARBOHYDRATE DIET; CELL SIZE; CONTROLLED STUDY; EDEMA; ELECTROLYTE BLOOD LEVEL; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAABDOMINAL FAT; KIDNEY; LIVER; MALE; METABOLIC SYNDROME X; NONHUMAN; POTASSIUM BLOOD LEVEL; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY; SODIUM BLOOD LEVEL; SPECTROPHOTOMETRY; SUBCUTANEOUS FAT; SUGAR INTAKE; WATER RETENTION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT;

RATTUS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADMINISTRATION, ORAL; ANGIOTENSIN II; ANIMALS; DIETARY SUCROSE; EDEMA; GLYCYRRHIZIC ACID; KIDNEY; LEPTIN; LIVER; MALE; METABOLIC SYNDROME X; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; SODIUM;

EID: 84908667347     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6114856     Document Type: Article

References (40)

1. Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z. The metabolic syndrome. Lancet 2005, 365, 1415–1421.
2. Alberti, K.G.; Zimmet, P.; Shaw, J. Metabolic syndrome—A new world-wide definition. A consensus statement from the international diabetes federation. Diabet. Med. 2006, 23, 469–480.
3. Chandramouli, C.; Yong, S.T.; Lam, Y.L.; Ton, S.H.; Kadir, K.A. Glycyrrhizic acid improves lipid and glucose metabolism in high-sucrose-fed rats. J. Endocrinol. Metab. 2011, 1, 125–141.
4. Shimono, K.; Tsutsumi, K.; Yaguchi, H.; Omura, M.; Sasano, H.; Nishikawa, T. Lipoprotein lipase promoting agent, NO-1886, modulates adrenal functions: Species difference in effects of NO-1886 on steroidogenesis. Steroids 1999, 64, 453-459.
5. Post, S.M.; Duez, H.; Gervois, P.P.; Staels, B.; Kuipers, F.; Princen, H.M. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1840-1845.
6. Yki-Jarvinen, H. Thiazolidinediones. N. Engl. J. Med. 2004, 351, 1106-1118.
7. Masoudi, F.A.; Inzucchi, S.E.; Wang, Y.; Havranek, E.P.; Foody, J.M.; Krumholz, H.M. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: An observational study. Circulation 2005, 111, 583-590.
8. Fiore, C; Eisenhut, M.; Krausse, R.; Ragazzi, E.; Pellati, D.; Armanini, D.; Bielenberg, J. Antiviral effects of Glycyrrhiza species. Phytother. Res. 2008, 22, 141-148.
9. Eu, C.H.; Lim, W.A.; Ton, S.H.; Kadir, K.A. Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats. Lipids Health Dis. 2010, 9, 81-90.
10. Lim, W.Y.; Chia, Y.Y.; Liong, S.Y.; Ton, S.H.; Kadir, K.A.; Husain, S.N. Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats. Lipids Health Dis. 2009, 8, 31, doi:10.1186/1476-511X-8-31.
11. Isbrucker, R.A.; Burdock, G.A. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul. Toxicol. Pharmacol. 2006, 46, 167-192.
12. Ploeger, B.A.; Meulenbelt, J.; DeJongh, J. Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Toxicol. Appl. Pharmacol. 2000, 162, 177-188.
13. Tomlinson, J.W.; Stewart, P.M. 11β-Hydroxysteroid dehydrogenase type 1 as a therapeutic target in the metabolic syndrome. Drug Discov. Today Ther. Strateg. 2005, 2, 93-96.
14. Uum, S.H. The role of 11β-hydroxysteroid dehydrogenase in the pathogenesis of hypertension. Cardiovasc. Res. 1998, 38, 16-23.
15. Seckl, J.R.; Walker, B.R. Minireview: 1 1β-Hydroxysteroid dehydrogenase type 1—A tissue-specific amplifier of glucocorticoid action. Endocrinology 2001, 142, 1371-1376.
16. Sheppard, K.; Funder, J.W. Mineralocorticoid specificity of renal type I receptors: In vivo binding studies. Am. J. Physiol. 1987, 252, E224-E229.
17. Stormer, F.C.; Reistad, R.; Alexander, J. Glycyrrhizic acid in liquorice—Evaluation of health hazard. Food Chem. Toxicol. 1993, 31, 303-312.
18. Armanini, D.; Wehling, M.; Weber, P.C. Mineralocorticoid effector mechanism of liquorice derivatives in human mononuclear leukocytes. J. Endocrinol. Investig. 1989, 12, 303-306.
19. Armanini, D.; Lewicka, S.; Pratesi, C; Scali, M.; Zennaro, M.C.; Zovato, S.; Gottardo, C; Simoncini, M.; Spigariol, A.; Zampollo, V. Further studies on the mechanism of the mineralocorticoid action of licorice in humans. J. Endocrinol. Investig. 1996, 19, 624-629.
20. Armanini, D.; Nacamulli, D.; Francini-Pesenti, F.; Battagin, G.; Ragazzi, E.; Fiore C. Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroids 2005, 70, 538–542.
21. Armanini, D.; de Palo, C.B.; Mattarello, M.J.; Spinella, P.; Zaccaria, M.; Ermolao, A.; Palermo, M.; Fiore, C.; Sartorato, P.; Francini-Pesenti, F. et al. Effect of licorice on the reduction of body fat mass in healthy subjects. J. Endocrinol. Investig. 2003, 26, 646–650.
22. Bernardi, M.; D’Intino, P.E.; Trevisani, F.; Cantelli-Forti, G.; Raggi, M.A.; Turchetto, E.; Gasbarrini, G. Effects of prolonged ingestion of graded doses of licorice by healthy volunteers. Life Sci. 1994, 55, 863–872.
23. Mori, T.; Kobayashi, K.; Sakamaki, S.; Sugiya, Y. Effects of oral administration of glycyrrhizin and its combinations on urine volume and electrolyte metabolism in rats. Pharmacometrics 1987, 34, 293–301.
24. Rossi, T.; Vampa, G.; Benvenuti, S.; Pini, L.A.; Galatulas, I.; Bossa, R.; Castelli, M.; Ruberto, A.I.; Baggio, G. Glycyrrhizin and 18-glycyrrhetinic acid: A comparative study of the pharmacological effects induced in the rat after prolonged oral treatment. In Vivo 1994, 8, 317–320.
25. Rossi, T.; Fano, R.A.; Castelli, M.; Malagoli, M.; Ruberto, A.I.; Baggio, G.; Zennaro, R.; Migaldi, M.; Barbolini, G. Correlation between high intake of glycyrrhizin and myolysis of the papillary muscles: An experimental in vivo study. Pharmacol. Toxicol. 1999, 85, 221–229.
26. Shinozaki, K.; Ayajiki, K.; Nishio, Y.; Sugaya, T.; Kashiwagi, A.; Okamura, T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertens. J. Am. Heart Assoc. 2004, 43, 255–262.
27. Van Dijk, D.J.; Boner, G.; Giler, S.; Erman, A. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat. J. Renin-Angiotensin-Aldosterone Syst. 2001, 2, 193–198.
28. Harte, A.; McTernan, P.; Chetty, R.; Coppack, S.; Katz, J.; Smith, S.; Kumar, S. Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation 2005, 111, 1954–1961.
29. Kobayashi, R.; Nagano, M.; Nakamura, F.; Higaki, J.; Fujioka, Y.; Ikegami, H.; Mikami, H.; Kawaguchi, N.; Onishi, S.; Ogihara, T. Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats. Hypertension 1993, 21, 1051–1055.
30. Kamide, K.; Hori, M.T.; Zhu, J.-H.; Barrett, J.D.; Eggena, P.; Tuck, M.L. Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system. Hypertension 1998, 32, 482–487.
31. Kamide, K.; Rakugi, H.; Ogihara, T. Insulin resistance and the renin-angiotensin-aldosterone system in metabolic syndrome and obesity-related hypertension. Curr. Hypertens. Rev. 2010, 6, 100–103.
32. Boden, G.; Chen, X.; Mozzoli, M.; Ryan, I. Effect of fasting on serum leptin in normal human subjects. J. Clin. Endocrinol. Metab. 1996, 86, 3419–3423.
33. Kolaczynski, J.W.; Ohannesian, J.P.; Considine, R.V.; Marco, C.C.; Caro, J.F. Response of leptin to short-term and prolonged overfeeding in humans. J. Clin. Endocrinol. Metab. 1996, 81, 4162–4165.
34. Lee, M.J.; Wang, Y.; Ricci, M.R.; Sullivan, S.; Russell, C.D.; Fried, S.K. Acute and chronic regulation of leptin synthesis, storage, and secretion by insulin and dexamethasone in human adipose tissue. Endocrinol. Metab. 2007, 292, 58–64.
35. Koike, T.; Liang, J.; Wang, X.; Ichikawa, T.; Shiomi, M.; Liu, G.; Sun, H.; Kitajima, S.; Morimoto, M.; Watanabe, T. et al. Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. J. Biol. Chem. 2004, 279, 7521–7529.
36. Adams, M.; Monatague, C.T.; Prins, J.B.; Holder, J.C.; Smith, S.A.; Sanders, L.; Digby, J.E.; Sewter, C.P.; Lazar, M.A.; Chatterjee, V.K. et al. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J. Clin. Investig. 1997, 100, 3149–3153.
37. De Souza, C.J.; Eckhardt, M.; Gagen, K.; Dong, M.; Chen, W.; Laurent, D.; Burkey, B.F. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001, 50, 1863–1871.
38. Bogacka, I.; Xie, H.; Bray, G.A.; Smith, S.R. The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care 2004, 27, 1660–1667.
39. Martin, G.; Schoonjans, K.; Staels, B.; Auwerx, J. PPARγ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis 1998, 137, S75–S80.
40. Laplante, M.; Festuccia, W.T.; Soucy, G.; Gelinas, Y.; Lalonde, J.; Berger, J.P.; Deshaies, Y. Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism. Diabetes 2006, 55, 2771–2778.